Showing posts with label
FDA
.
Show all posts
Showing posts with label
FDA
.
Show all posts
Tuesday, July 03, 2018
HANDS OFF Safety Alert: US Food and Drug Administration reports potential health risks to people exposed to altrenogest products for horses
›
The following warning was issued today by the FDA's Center for Veterinary Medicine in Rockville, Maryland: The U.S. Food and Drug...
Wednesday, December 13, 2017
Beyond Navicular Disease: Racing Commissioners Call for Regulation of Bisphosphonates in Sale Horses
›
Portions of the following information is edited from a press release: The Association of Racing Commissioners International (ARCI) i...
Monday, July 28, 2014
Navicular Syndrome: Does FDA Approval of Tildren and Osphos Change Anything?
›
From bone to zone: Focus on navicular-type lameness has evolved from concentrating on identifying bone defects visible in radiography to...
Thursday, April 19, 2007
AAEP Statement on FDA Withdrawal of Pergolide for Human Use: Will It Still Be Available for Horses?
›
The American Association of Equine Practitioners (AAEP) has issued this statement to its members about the potential crisis of pergolide...
›
Home
View web version
